Mupirocin NDC 51672-1312

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-1312Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-1312Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51672-1312-0	51672131200	1 TUBE in 1 CARTON (51672-1312-0) / 22 g in 1 TUBEMarketed from Sep 23, 2005
51672-1312-1	51672131201	1 TUBE in 1 CARTON (51672-1312-1) / 15 g in 1 TUBEMarketed from Sep 23, 2005
51672-1312-2	51672131202	1 TUBE in 1 CARTON (51672-1312-2) / 30 g in 1 TUBEMarketed from Sep 23, 2005

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mupirocin
Generic name (nonproprietary): mupirocin
Active ingredients: Mupirocin — 20 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065170
Marketing start: Sep 23, 2005
Listing expires: Dec 31, 2026
Other FDA classes: RNA Synthetase Inhibitors (Mechanism)
Identifiers: Product ID 51672-1312_3961a44e-34c2-d648-e063-6394a90a974eSPL ID 3961a44e-34c2-d648-e063-6394a90a974eSPL set ID 900bb675-2f03-47e3-854e-257ec4831332RxCUI 106346UNII D0GX863OA5
Pharmacologic class: RNA Synthetase Inhibitor Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672131200 followed by a unit qualifier and the quantity

Package 51672-1312-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2025.

Indications (excerpt from the label)

Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) . Mupirocin ointment is an RNA synthetase inhibitor antibacterial indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes . ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065170

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065170
Product	Strength	Form · route	Labeler	Product NDC
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Sportpharm LLC	85766-207
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	NuCare Pharmaceuticals,Inc.	68071-4321
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Proficient Rx LP	63187-151
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	PAI Holdings, LLC dba PAI Pharma	0121-1076
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	AvPAK	50268-568
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Advanced Rx Pharmacy of Tennessee, LLC	80425-0254
Mupirocin	Mupirocin 20 mg/g	OintmentTopical	Lohxa	70166-355